Financial Disclosure by Federal Officials, and More from CRS
New and updated reports from the Congressional Research Service that Congress has withheld from broad public distribution include the following.
Financial Disclosure by Federal Officials and Publication of Disclosure Reports, August 22, 2013
Defense Surplus Equipment Disposal: Background Information, August 22, 2013
Iraq: Politics, Governance, and Human Rights, August 22, 2013
The United Arab Emirates (UAE): Issues for U.S. Policy, August 20, 2013
Changing the Federal Reserve’s Mandate: An Economic Analysis, August 12, 2013
The Affordable Care Act and Small Business: Economic Issues, August 15, 2013
Financing Natural Catastrophe Exposure: Issues and Options for Improving Risk Transfer Markets, August 15, 2013
Reauthorizing the Office of National Drug Control Policy: Issues for Consideration, August 13, 2013
International Drug Control Policy: Background and U.S. Responses, August 13, 2013
Mexico’s Peña Nieto Administration: Priorities and Key Issues in U.S.-Mexican Relations, August 15, 2013
Latin America and the Caribbean: Key Issues for the 113th Congress, August 9, 2013
Uzbekistan: Recent Developments and U.S. Interests, August 21, 2013
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.